
A comprehensive examination of what we know to be facts about fenbendazole and cancer, including the academic and medical evidence, practical realities, financial costs, and unknowns. This information is not medical advice, and I am not a doctor.
| Platform | Pricing | Only free issues | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 61 | Founded | 2 months ago | Last Issue | 7 days ago |
| Active | |||||

Source document:
Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort
https://www.researchgate.net/profile/Nicolas-Hulscher/publication/403583165…
Breast cancer remains a formidable global adversary, claiming lives through the dual threats of advanced metastasis and the swift evolution of drug resistance. Developing a new oncological weapon from scratch is...
For individuals born with Familial Adenomatous Polyposis (FAP), the future can feel like a ticking clock. This condition, caused by a germline mutation in the APC tumor suppressor gene, triggers the growth of hundreds or even thousands of p...
Cancer cytotoxicity refers to the ability of a compound or treatment to selectively damage or kill cancer cells while minimizing harm to healthy tissues. In the context of drug repurposing, anti-parasitic anthelmintics—such as fenbendazole,...
Subscribers, engagement, traffic and sponsorship for Fenbendazole & Cancer.
| Subscribers | Engagement | 74 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #139 |
The writers behind this newsletter.
A comprehensive examination of what we actually know about Fenbendazole and cancer, including the science, the evidence, the practical realities, and unknowns.
You can find recent issues that have been published by Fenbendazole & Cancer on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Fenbendazole & Cancer, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Fenbendazole & Cancer as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Fenbendazole & Cancer using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Fenbendazole & Cancer. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.